Brief: Kubota Pharmaceutical Holdings says unit Acucela receives patent covering method of use for emixustat hydrochloride
Sept 11 (Reuters) - Kubota Pharmaceutical Holdings Co Ltd
4596.T
* Says unit Acucela Inc received a patent (No. 9,737,496 B2)
covering method of use for emixustat hydrochloride from the
United States Patent and Trademark Office (USPTO)
Source text in Japanese:https://goo.gl/GDpJ2E
Further company coverage: 4596.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))
Recent news on Kubota Pharmaceutical Holdings
See all newsTable: Kubota Pharmaceutical Holdings 6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Brief: Kubota Vision Signs Supply & Licensing Agreement With Laboratoires Kôl
Table: Kubota Pharmaceutical Holdings -2025 parent results
Table: Kubota Pharmaceutical Holdings -2025 group results (IFRS)